SquamousCellCarcinomaofSkin near Tampa, FL

Care Philosophy: Dr Michael Jain is an Associate Member and ICE-T Medical Director in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr Jain earned his MD and PhD at McGill University in Montrv©al, in the province of Quv©bec, Canada. His PhD in Cell Biology was completed under the supervision of Dr John Bergeron. Dr Jain completed an Internal Medicine Residency and a Hematology Residency at the University of Toronto. He completed a Clinician Scientist Training Program and Clinical Fellowship in Lymphoma and Autologous Stem Cell Transplantation at Princess Margaret Cancer Center, University of Toronto.

Biography: Dr. David Swoboda is a hematologist-oncologist at Tampa General Hospital who specializes in malignant hematology. Prior to joining Tampa General, he was a chief hematology-oncology fellow at H. Lee MoffittCancer Center in Tampa after serving as a chief resident at Medstar Georgetown University Hospital in Washington, D.C. Dr. Swoboda received his medical degree from Florida State University College of Medicine in Tallahassee, where he was the president of the InternalMedicine Interest Group. Dr. Swoboda enjoys developing a close relationship with his patients and their families, building trust, and gaining a full understanding of each disease in order to provide personalized, comprehensive care. His research is directed toward acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative disorders. He has published several entries in peer-reviewed journals and has participated in numerous scientific abstract presentations. Dr. Swoboda has memberships with the society for Hematology Oncology, American Society of hematology, and American Society of Clinical Oncology.

Care Philosophy: Alberto A Chiappori, MD currently serves as Senior Member of Oncology and Medicine for the Thoracic Oncology Program at the H Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. He has been a member of the Thoracic Oncology Program at Moffitt since 2001. Dr Chiappori received his MD from the Universidad Peruana Cayetano Heredia in Lima, Peru. After graduation, he completed his residency at Southern Illinois University School of Medicine in Springfield, Illinois. He then went on to finish his fellowship and senior fellowship in medical oncology-hematology at Vanderbilt University School of Medicine in Nashville, Tennessee. Dr Chiappori has been Board Certified in Medical Oncology since 1997.

Care Philosophy: Dr. Naraev believes in compassionate, personalized care that is focused on his patients, their hopes, needs and quality of life.

Care Philosophy: Dr Kirtane is an Assistant Member in the Department of Head and Neck-Endocrine Oncology and Medical Director for Solid Tumor Cellular Therapy. Dr Kirtane received his MD degree from The University of Florida College of Medicine. He completed an Internal Medicine Residency at Duke University Medical Center. Dr Kirtane completed a Hematology/Oncology Fellowship at the University of Washington and a Post-Doctoral Fellowship in Oncology at Fred Hutchinson Cancer Research Center. His clinical focus is patients with head and neck-endocrine cancers. He works on the development of innovative cellular therapies for solid tumor cancers and is focused on increasing representation of underrepresented groups to clinical trials.

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.